Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New inhibitors of ERK2, GSK-3, PKA and CDK2 presented by Vertex

Oct. 11, 2004

New CDK inhibitors in early development at Pfizer

Oct. 11, 2004

Preclinical studies reveal anticancer potential of AZD-0530

Oct. 8, 2004

Aplidin granted orphan drug status for multiple myeloma

Oct. 8, 2004

Orphan drug status for CoFactor for pancreatic cancer

Oct. 8, 2004

New Hsp90 inhibitors and their use in cancer and other disorders

Oct. 8, 2004

New research milestone in Pharmacopeia/Schering-Plough oncology collaboration

Oct. 8, 2004

ARQ-501 induces antitumor effects in advanced cancer patients

Oct. 8, 2004

KML-001 induces senescence, chromosomal instability in cancer cell lines with short telomerases

Oct. 8, 2004

Degarelix reduces testosterone and PSA levels in prostate cancer patients

Oct. 7, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.